Usually living as a soil saprophyte, the filamentous fungus Scedosporium boydii may also cause various infections in human. Particularly, it is one of the major causative agents of fungal colonization of the airways in patients with cystic fibrosis (CF). To compete with other microorganisms in the environment, fungi have evolved sophisticated strategies, including the production of secondary metabolites with antimicrobial activity that may also help them to establish successfully within the respiratory tract of receptive hosts. Here, the culture filtrate from a human pathogenic strain of S. boydii was investigated searching for an antibacterial activity, mainly against the major CF bacterial pathogens. A high antibacterial activity against Staphylococcus aureus, including methicillin-resistant strains of this species, was observed. Bio-guided fractionation and analysis of the active fractions by nuclear magnetic resonance or by high-performance liquid chromatography and high-resolution electrospray ionization-mass spectrometry allowed us to identify boydone A as responsible for this antibacterial activity. Together, these results suggest that this six-membered cyclic polyketide could be one of the virulence factors of the fungus. Genes involved in the synthesis of this secreted metabolite are currently being identified in order to confirm the role of this polyketide in pathogenesis.
INTRODUCTION
Within the Scedosporium genus, the filamentous fungus Scedosporium boydii is one of the major pathogens with S. apiospermum and S. aurantiacum (Gilgado et al. 2005 (Gilgado et al. , 2008 Lackner et al. 2014) . These opportunistic fungi may be responsible in human for various diseases ranging from localized infections such as subcutaneous mycetoma to severe and often fatal disseminated infections in immunocompromised patients, particularly in lung transplant recipients (Giraud and Bouchara 2014) . Nevertheless, these fungi have gained an increasing attention recently because of their worldwide recognition as major pathogens in patients with cystic fibrosis (CF). In CF, the Scedosporium genus ranks the second among the filamentous fungi colonizing the respiratory tract, after Aspergillus fumigatus (Pihet et al. 2008; Blyth et al. 2010) and S. boydii is the most common Scedosporium species in France (Zouhair et al. 2013) .
To survive in the environment, fungi have evolved sophisticated strategies allowing them to compete with the other microorganisms, especially bacteria which are more rapidly growing. Among them, is the production of a diverse array of secondary metabolites with antibacterial activity that may be considered as virulence factors for Scedosporium species since they may help them to establish within the respiratory tract of the patients. Indeed, the airways in CF are frequently colonized by various bacteria, especially Staphylococcus aureus and Pseudomonas aeruginosa that are often difficult to treat because of their progressive evolution towards methicillin resistance for St. aureus, or a multiresistant mucoid phenotype for P. aeruginosa. Nevertheless, very few antimicrobial metabolites have been characterized from Scedosporium species, including tyroscherin and its derivatives (Kamigiri et al. 2004; Nirma, Eparvier and Stien 2013) or pseudallin (Su et al. 2012 ) that exhibit an antifungal activity, and some dioxopiperazine derivatives with antibacterial properties like brevianamide F and fumitremorgin C (Zhang et al. 2007) or some gliotoxin (Li et al. 2006) or aranotin (Wu et al. 2014) derivatives. This study therefore was designed in order to identify secondary metabolites secreted by S. boydii that could allow the fungus to compete with CF-associated bacterial pathogens.
MATERIALS AND METHODS

Fungal strain and growth conditions
Scedosporium boydii strain IHEM 15155, originally isolated from human sputum, was used throughout this study. This strain was maintained by weekly passages on yeast extract-peptonedextrose (YPD; containing in g/L: yeast extract, 5; peptone, 10; and glucose, 20) agar plates.
Conidia (10 9 ) harvested from 7-day-old cultures on YPDA as previously described (Ghamrawi et al. 2015; Mina et al. 2015) were inoculated in YPD broth (200 mL per 1 L flasks). After 7 days of incubation at 37
• C, the culture medium was filtered to remove all fungal elements and finally 25-fold concentrated by lyophilization before liquid-liquid extraction.
Liquid/liquid extraction
Concentrated culture filtrate was successively extracted with various organic solvents of increasing polarity: cyclohexane, dichloromethane, ethyl acetate and butanol (>99.8% purity; Sigma Aldrich, Santa Clara, CA), three washes each, approximately 200 mL per wash. The organic phase was collected and evaporated under reduced pressure (BÜCHI Labortechnik AG, Flawil, Switzerland). 
Determination of antibacterial activity
High-performance liquid chromatography-UV-visible analysis
Profiling of the different extracts was performed using an HP-1100 liquid chromatographic equipment (Agilent Technologies, Santa Clara, CA) coupled to a photo diode array UV-visible detector. Separation was achieved at a flow rate of 1 mL/min, on a nucleosyl C-18 column (BDS hypersil C18, 250 × 4.6 mm, 5 μM; Thermo Fisher Scientific, Waltham, MA). Twenty microliters of the extracts (5 or 10 mg/mL) were injected on the column and the mobile phase consisted of 0.1% formic acid in water (HPLC grade, solvent A) and acetonitrile (ACN, HPLC grade) as previously described (Calmes et al. 2013; Boisard et al. 2015) .
Microfractionation of the cyclohexane extract
Aliquots of the cyclohexane extract (100 mg/mL) were microfractionated at room temperature (25 • C) on the analytical HPLC column described above with UV detection. Elution was achieved at a flow rate of 1 mL/min using an original isocratic elution at 80% ACN in solvent A for 40 min, and identical peaks obtained for the different aliquots were pooled.
Nuclear magnetic resonance analysis
Nuclear magnetic resonance (NMR) experiments were performed using a Bruker 500 MHz Avance III spectrometer (Bruker BioSpin, Rheinstetten, Germany) equipped with a DCH 13C/1H Cryoprobe (Bruker Biospin, Fallanden, Switzerland). Standard pulse sequences and parameters were used to obtain 1 H and 2D
NMR spectra (COSY, edited HSQC, HMBC and NOESY) in deuterated methanol CD 3 OD (d-99, 96%-δ 1H 3.31 ppm-δ 13C 49.00 ppm) as internal standard at 300 K.
High-resolution electrospray ionization-mass spectrometry
The dichloromethane extract (10 mg/mL) was analyzed in UPLCgrade methanol, by injection of 2 μL on a Kinetex C18 column (100 × 2.1 mm, 2.6 μm) maintained at 40
• C on a Prominence ultrafast liquid chromatography coupled to high-resolution electrospray ionization-mass spectrometry combining ion trap and time of flight (TOF)-MS analyzers (Shimadzu instrument, Kyoto, Japan). Elution conditions consisted in a first isocratic step of 15% ACN during 2 min, followed by a 15% to 100% ACN gradient for 23 min, with a final isocratic step of 100% ACN for 5 min and equilibration in 15% ACN during 5 min. Detection using ESI was performed in both positive and negative ionization modes in the mass range m/z 100-1000 with a mass accuracy of 7 ppm and a resolution of 10 000 at m/z 500.
Data treatment
Automatic feature detection was performed between 1 and 30 min with MZmine 2 software (Pluskal et al. 2010 ) using the parameters selected according to the TOF-MS detector. Peaks with at least a 0.03-min-width and an intensity greater than 10 000 counts (in both positive and negative modes) were picked with a 10 ppm m/z tolerance and the generated peak lists were deconvoluted. 
RESULTS
Antibacterial activity of the culture filtrate
Liquid-liquid extraction
Liquid/liquid extraction was performed from the concentrated culture filtrate (56 mL) using successively different solvents of increasing polarity. Dichloromethane and ethyl acetate permitted the highest rates of extraction, leading after evaporation to 55.7 and 50.1 mg of dried material, respectively, whereas the dried material weighted only 6.7 mg, 7.3 mg and 12 g for the cyclohexane extract, the butanol extract and the aqueous phase, respectively. The antibacterial activity of each extract was evaluated against St. aureus, showing growth inhibition zones with the cyclohexane (19 ± 2 mm in diameter), dichloromethane (19 ± 2 mm) and ethyl acetate (20 ± 1 mm) extracts. No activity was found for the butanol extract and the aqueous phase.
Bio-guided fractionation and high-performance liquid chromatography-UV-visible analysis
Analysis of the cyclohexane extract by high-performance liquid chromatography-UV-visible (HPLC-UV-Vis) showed, at 360 nm, the presence of a single peak (compound X) with a retention time (Rt) of 18.86 min (eluted from 84.8% to 85.9% ACN) and (Chang et al. 2013 ). c13 C chemical shifts determined with edited HSQC and HMBC spectra. no signal at the other wavelengths. Conversely, HPLC-UV-Vis revealed for the dichloromethane and the ethyl acetate extracts similar profiles, with a large number of peaks compared to the cyclohexane extract. Nevertheless, a major peak was seen at 360 nm on HPLC-UV-Vis profiles of both extracts. Therefore, we first focused on the identification of this compound in the cyclohexane extract.
Analysis of compound X
Microfractionation of the cyclohexane extract was performed using a semi-preparative HPLC, leading to the obtention of 4.1 mg of a yellowish oil. NMR analysis of compound X (Table  1) showed the presence of 5 degrees of unsaturation. The 13 C data from edited HSQC and HMBC spectra gave 17 carbon resonances with the presence of five methyl, four methylene, two methine resonances and six quaternary carbons including two ketone carbonyls at δ 198.6 and 201.7 ppm. The 1 H resonances of compound X showed five branchings, a first with two methylene (δ 3.69, t, J 5.0 and δ 3.51, t, J 5.0) connected to heteroatoms, HO-9 for C-9 (δ 62.0) and N-7 for C-8 (δ 52.6) that was identified as a methinethanolylamine chain according to 3 J HMBC correlations between H-8 (δ 3.51) and C-7 (δ 156.2) and between H-7 (δ 7.80) and C-8 (δ 52.6). This moiety was connected to C-6 position, based on the 2,3 J HMBC correlations between H-7 (δ 7.80) and C-6 (δ 102. and C-3 (δ 198.6 ppm). On other hand, NOE correlations (H8-H7, H7-H15, H17-H13, H13-H12, H10-H11) observed on the NOESY spectrum confirmed the cyclic structure and the position of the different branchings, thus revealing compound X to be a six-membered cyclic polyketide, more precisely boydone A, a secondary metabolite already described in S. boydii by Chang et al. (2013) (Fig. 1) .
HPLC-ESI-HRMS
HPLC-ESI-HRMS analysis was also conducted on the dichloromethane extract, to confirm the presence of this polyketide as its major compound. The results clearly showed the occurrence of a major peak (Rt = 8.95 min), corresponding to m/z 310.1996 (+) and 308.1850 (-) (Fig. 1) . The molecular formula of this compound revealed to be C 17 H 27 NO 4 (m/z 310.2013 calcd: 310.2013 ) that corresponded to boydone A.
In addition, a peak picking analysis on the minor signals was performed. Most of the m/z values observed were comprised between 200 and 450. Because of the low intensity of some of these peaks, of too many hits and of the lack of an exhaustive database for secondary metabolites in Scedosporium species, most of the corresponding compounds could not be identified. However, according to searches in appropriate databases (Dictionary of Natural Products DNP database 25.2 Copyright C 2017; Dictionary of Marine Natural Products; ChEBI, KeGG, KNApSAcK, AntiBase and the Universal Natural Product databases), acrodontiolamide and cyclo(phenylalanyl-prolyl) (3S,8aS)-form were associated to the peaks at m/z = 434.9963 (Rt = 5.89 min) (Steiman et al. 1995) and m/z = 245.1272 (Rt = 3.98 min) (Pavlaskova et al. 2010) , respectively. Other cyclic peptides were also identified, including cyclo(prolyl-valyl) and cyclo(hydroxyprolyl-leucyl) that were associated to the peaks at m/z 197.1279 (Rt = 1.57 min) and 227.1380 (Rt = 1.68 min), respectively, and cyclo(leucyl-prolyl) that was associated to the peaks at m/z = 211.1436 (Rt = 2.38 and 2.89 min).
DISCUSSION
CF patients are prone to pulmonary infections because of their sticky bronchial mucus. These infections are primarily caused by bacteria, mainly St. aureus and P. aeruginosa, which have a major deleterious impact on the lung function (LiPuma 2010; Bellis, Dehillotte and Lemonnier 2016; Marshall et al. 2016) . Colonization of the airways by filamentous fungi, including Scedosporium species, occurs later, at the beginning of adolescence (Pihet et al. 2008) . Blyth et al. (2010) have suggested that P. aeruginosa colonization may influence colonization/infection by Scedosporium species. A reciprocal antagonism between colonization of the airways/respiratory infection by Scedosporium species and mucoid P. aeruginosa was observed. Here, we did not find an antibacterial activity against P. aeruginosa, but an anti-staphylococcal activity. Interestingly, Blyth et al. (2010) also showed that prior therapy with anti-staphylococcal penicillins was a risk factor for colonization of the airways by Scedosporium species, suggesting that eradication of staphylococci from the airways is necessary for establishment of Scedosporium species in the respiratory tract.
In the environment, Scedosporium species continuously compete with other bacterial and fungal pathogens for access to nutriments. In this aim, they have developed protective mechanisms including the secretion of secondary metabolites with antimicrobial activity. For instance, it has been demonstrated that S. boydii produces antifungal metabolites such as pseudallin, tyroscherin and N-methyltyroscherin formate (Kamigiri et al. 2004; Su et al. 2012; Nirma, Eparvier and Stien 2013) . Other Scedosporium metabolites with antibacterial activity have also been reported like gliotoxin and two derivatives, bisdethiobis(methylthio)gliotoxin and dehydroxybisdethiobis(methylthio)gliotoxin, and these three compounds showed antibacterial activity against St. aureus (Li et al. 2006) . The analyses of the active extracts did not show the presence of ions m/z = 327, 341 and 357, corresponding to gliotoxin and its derivatives. Likewise, several aranotin derivatives were identified from S. boydii and, among them, it was shown that boydine B exhibited antibacterial activity against Bifidobacterium sp., Veillonella parvula, Anaerostreptococcus sp., Bacteroides vulgatus and Peptostreptococcus sp. (Wu et al. 2014) . Other dioxopiperazine derivatives have been identified by Zhang et al. (2007) , including fumitremorgin C, 12,13-dihydroxyfumitremorgin C and brevianamide F that exhibited a mild antibacterial activity against St. aureus. Here, we identified from the analysis of both the cyclohexane and dichloromethane extracts of the culture filtrate, boydone A as responsible for the anti-staphylococcal activity of the culture filtrate. This compound has already been identified by Chang et al. (2013) from an isolate of S. boydii recovered from the leaves of the littoral plant Sesuvium portulacastrum. Eight polyketides were recovered from an acetyl acetate extract, searching for compounds with anti-cancer activity, including mevalonolactone, fusidilactone, ovalicin, boydones A and B, and botryorhodines C, F and G. Among all these compounds, only boydone B and ovalicin showed growth inhibitory activity against the A549 lung cancer cell line. Boydone A was not effective, and no antibacterial activity was investigated (Chang et al. 2013) . Of note, acetyl acetate was the only solvent used for extraction of these polyketides.
Boydone A (2R, 11S) is an epimer of mycosphine B (2S, 11S), which has been identified in Mycosphaerella sp., an endophytic fungus (Asai et al. 2013) . Likewise, related compounds, namely similin B and ceratenolone, have been described from the coprophilous fungus Sporormiella similis (Weber et al. 1992) , now called Preussia similis, and the phytopathogenic fungus Ceratocystis minor (Ayer et al. 1987) , now called Ophiostoma minus, respectively. In both studies, ethyl acetate was the only solvent used for extraction. Additionally, whereas another polyketide from P. similis called similin A exhibited an antifungal activity against Sordaria fimicola and Ascobolus furfuraceus, but no activity against B. subtilis or St. aureus, no antimicrobial activity was investigated for similin B that is closer to boydone A (Weber et al. 1992) . Thus, boydone A is also produced by an environmental isolate of S. boydii, but this polyketide may also be important for pathogenicity of the fungus, allowing it to compete in the airways with the CF-associated bacterial pathogens.
In conclusion, our results showed that the six-membered cyclic polyketide previously described as boydone A is responsible for the anti-staphylococcal activity of S. boydii culture filtrate. This compound, which corresponds to the single peak detected for the cyclohexane extract, is the major compound of the dichloromethane extract of the culture filtrate, both extracts exhibiting this antibacterial activity, including against MRSA isolates. Structural analogs should be investigated to identify more potent compounds. Likewise, elucidation of the biosynthetic pathway of this polyketide should allow a better understanding of the role of this compound in pathogenicity of S. boydii.
